Lupagen is a medical device company specializing in cell and gene therapies. It develops delivery technologies for CAR-T, gene editing, and immunotherapy products. The company uses apheresis-based platform customized for ex-vivo autologous cell and gene therapies requiring genetic or cellular modification of selective populations of circulating peripheral blood mononuclear cells.